Literature DB >> 23172637

The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO).

R Manchanda1, M Godfrey, L A Wong-Taylor, M J Halaska, M Burnell, J P Grabowski, M Gultekin, D Haidopoulos, I Zapardiel, B Vranes, V Kesic, P Zola, N Colombo, R Verheijen, M Bossart, J Piek.   

Abstract

BACKGROUND: Primary data on training experiences of European gynaecological oncology trainees are lacking. This study aims to evaluate trainee profile, satisfaction and factors affecting the training experience in gynaecological oncology in Europe. PATIENTS AND METHODS: A web-based anonymous survey sent to ENYGO members/trainees in July 2011. It included sociodemographic information and a 22-item (1-5 Likert scale) questionnaire evaluating training experience in gynaecological oncology. Chi-square tests were used for evaluating the independence of categorical variables and t-test (parametric)/Mann-Whitney (non-parametric) tests for differences between two independent groups on continuous data. Cluster analysis was used to identify groupings in multivariate data and Cronbach's-alpha for questionnaire reliability. A multivariable linear regression model was used to assess the effect of variables on training satisfaction.
RESULTS: One hundred and nineteen gynaecological-oncology trainees from 31 countries responded. The mean age was 37.4 (S.D, 5.3) years and 55.5% were in accredited training posts. Two clusters identified in the cohort (Calinski-Harabasz, CH = 47.35) differed mainly by accredited training (P = 0.003). The training-satisfaction score (TSS) had high reliability (Cronbach's alpha, 0.951) and was significantly associated with accredited posts (P < 0.0005), years of training (P = 0.001) and salary (P = 0.002). The TSS was independent of age (P = 0.360), working hours (P = 0.620), overtime-pay (P = 0.318), annual leave (P = 0.933), gender (P = 0.545) and marital status (P = 0.731). Accredited programme trainees scored significantly higher than others in 17 of 22 aspects of training. The areas of greater need included advanced laparoscopic/urological/colorectal surgery, radiation oncology, palliative-care, cancer genetics and research opportunities.
CONCLUSIONS: Our data demonstrate the importance of accredited training and the need for harmonisation of gynaecological oncology training within Europe.

Entities:  

Mesh:

Year:  2012        PMID: 23172637     DOI: 10.1093/annonc/mds588

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  5 in total

1.  Current situation in gynecological oncology training in Spain: where we are and where we want to go.

Authors:  P Padilla-Iserte; L Minig; I Zapardiel; L Chiva; R Laky; J de Santiago
Journal:  Clin Transl Oncol       Date:  2017-08-31       Impact factor: 3.405

Review 2.  Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges.

Authors:  Carolyn Johnston; Joseph S Ng; Ranjit Manchanda; Audrey Tieko Tsunoda; Linus Chuang
Journal:  Gynecol Oncol Rep       Date:  2017-01-09

Review 3.  Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities.

Authors:  L Chuang; J Berek; T Randall; M McCormack; K Schmeler; R Manchanda; T Rebbeck; C J Jeng; D Pyle; M Quinn; E Trimble; R Naik; C H Lai; K Ochiai; L Denny; N Bhatla
Journal:  Gynecol Oncol Rep       Date:  2018-06-09

4.  How changing quality management influenced PGME accreditation: a focus on decentralization and quality improvement.

Authors:  Nesibe Akdemir; Kiki M J M H Lombarts; Emma Paternotte; Bas Schreuder; Fedde Scheele
Journal:  BMC Med Educ       Date:  2017-06-02       Impact factor: 2.463

Review 5.  Building a Personalized Medicine Infrastructure for Gynecological Oncology Patients in a High-Volume Hospital.

Authors:  Nicolò Bizzarri; Camilla Nero; Francesca Sillano; Francesca Ciccarone; Marika D'Oria; Alfredo Cesario; Simona Maria Fragomeni; Antonia Carla Testa; Francesco Fanfani; Gabriella Ferrandina; Domenica Lorusso; Anna Fagotti; Giovanni Scambia
Journal:  J Pers Med       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.